ISSN: 1073-2748

Journal Home

Journal Guideline

Cancer Control Q2 Unclaimed

SAGE Publications Ltd United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Control is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 80. It has an SJR impact factor of 0,698 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,698.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Hematology (Q2) Medicine (miscellaneous) (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,698

SJR Impact factor

80

H Index

134

Total Docs (Last Year)

440

Total Docs (3 years)

6091

Total Refs

1085

Total Cites (3 years)

428

Citable Docs (3 years)

2.39

Cites/Doc (2 years)

45.46

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Practical Applications of Digital Pathology

Cancer Genetics Knowledge and Beliefs and Receipt of Results in Ashkenazi Jewish Individuals Receiving Counseling for BRCA1/2 Mutations

Establishing Trusting Partnerships for Successful Recruitment of American Indians to Clinical Trials

Endoscopic Palliation for Inoperable Pancreatic Cancer

Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma

Pharmacology of Chemotherapy in the Older Cancer Patient

Primary Cutaneous B-Cell Lymphomas: Recent Advances in Diagnosis and Management

Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis

Selective Hepatic Artery Embolization for Treatment of Patients with Metastatic Carcinoid and Pancreatic Endocrine Tumors

Building Community Capacity to Participate in Cancer Prevention Research

Multidisciplinary Therapy of Stage IIIA Non - Small-Cell Lung Cancer: Long-term Outcome of Chemoradiation with or without Surgery

Lymphatic Mapping for Melanoma: Long-term Results of Regional Nodal Sampling with Radioguided Surgery

SHOW MORE ARTICLES

Functional Health Literacy, Chemotherapy Decisions, and Outcomes among a Colorectal Cancer Cohort

A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer

Liver Resection and Surgical Strategies for Management of Primary Liver Cancer

Circulating Tumor Cells: A Window into Tumor Development and Therapeutic Effectiveness

Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma from Racially and Ethnically Diverse Populations

Premalignant and Malignant Prostate Lesions: Pathologic Review

Long-Term Oncologic Outcomes for Patients Undergoing Volatile Versus Intravenous Anesthesia for Non-Small Cell Lung Cancer Surgery

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis

Interferon in the Treatment of Multiple Myeloma

Association Between Positive Cultures During Admission and 1-Year Mortality in Patients With Cancer Receiving Perioperative Intensive Care

Melatonin-Deficient Balb/c Mice and Their Use in Cancer Research

Comparison of Outcomes Between McKeown and Sweet Esophagectomy in the Elderly Patients for Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis